Effectiveness of influenza vaccination on in-hospital death and recurrent hospitalization in older adults with cardiovascular diseases.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 07 05 2022
revised: 21 05 2022
accepted: 26 05 2022
pubmed: 3 6 2022
medline: 9 9 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

There is limited evidence on the effectiveness of influenza vaccination on hospitalization outcomes by cardiovascular disease (CVD) subtypes or comorbidities. This study involved 713,488 records of hospitalization of adults ≥60 years with CVD from the Beijing Urban Employee Basic Medical Insurance database. Logistic regression with generalized estimating equations was conducted to estimate the effectiveness of influenza vaccination on in-hospital death and recurrent hospitalization, adjusting for unmeasured confounders. The coverage of influenza vaccination was only 13.3% among older adults hospitalized for CVD. Influenza vaccination was associated with 15% (odds ratios 0.85 [0.74, 0.99]) lower risk of in-hospital death among patients with CVD, with stronger associations in patients with stroke. Influenza vaccination was associated with 6% (0.94 [0.88, 0.99]) and 28% (0.72 [0.56, 0.93]) lower risks of recurrent hospitalization for ischemic heart disease (IHD) and respiratory disease in patients with IHD, but there were no clear associations in patients with stroke. For in-hospital death, the protective association of influenza vaccination was stronger in patients with fewer comorbidities and was similar to that of joint vaccinations of influenza and pneumococcal vaccinations. The protective association of influenza vaccination on CVD hospitalization outcomes serves as the evidence base to increase the uptake of influenza vaccination among older adults in China.

Identifiants

pubmed: 35654282
pii: S1201-9712(22)00323-X
doi: 10.1016/j.ijid.2022.05.059
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-168

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

Yuanjie Pang (Y)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.

Xiaofan Liu (X)

Department of Biostatistics, Yale School of Public Health, New Haven, CT.

Guangqi Liu (G)

Department of Global Health, School of Public Health, Peking University, Beijing, China.

Min Lv (M)

Institute for Immunization and Prevention, Beijing Center for Disease Prevention and Control, Beijing, China.

Ming Lu (M)

Department of Biomedical Informatics, School of Basic Medicine, Peking University, Beijing, 100191, China.

Jiang Wu (J)

Institute for Immunization and Prevention, Beijing Center for Disease Prevention and Control, Beijing, China.

Yangmu Huang (Y)

Department of Global Health, School of Public Health, Peking University, Beijing, China. Electronic address: ymhuang@bjmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH